| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | C |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | B |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | B |
| 15. Total Score | C4,7,8,10,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Follicle stimulating hormone (FSH) |
| Unit | U / L |
| Overall Analytical Principle Method | Immunoassay; Time-resolved immunofluorometric assay (TR-IMFA) |
| Number of Subjects | 31 |
| Number of Subjects included in BV estimation | 31 |
| Ethinicity | Unknown |
| Age Mean / Median | 23.0 |
| Age Min | 20.0 |
| Age Max | 34.0 |
| Age SD | |
| Number of Males | 31 |
| Number of Females | 0 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 2 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Day |
| Sampling Times | Start Time:
08.00
End Time: |
| Number of Samples | 2 |
| Average Number of Samples Used for BV Estimation | 2.0 |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 7.5 |
| Calculated Confidence Intervals of CVi | Lower: 3.71, Upper: 10.37 |
| Estimates of CVg | 55.3 |
| Calculated Confidence Intervals of CVg | Lower: 44.20, Upper: 73.69 |
| Analytical CV | 3.3 |
| Calculated Confidence Intervals of Analytical CV | Lower: 2.13, Upper: 7.27 |
| Measurand Mean | 3.3 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |